2026-01-16 11:52:02
CellCarta acquires Biogazelle to strengthen its genomic capabilities and expand into digital PCR (dPCR) services
Health/ 2023-07-22
CellCarta acquires Biogazelle to strengt...

This acquisition solidifies CellCarta\'s leadership position in genomic services with a unique combination of assay development and global c...

Alterity Therapeutics Announces First Regulatory Authorization to Proceed with ATH434 Phase 2 Clinical Trial
Corporate/ 2023-07-23
Alterity Therapeutics Announces First Re...

MELBOURNE,Australia,Dec. 14,2021-- Alterity Therapeutics (ASX: ATH,NASDAQ: ATHE) ("Alterity" or "the Company"),a biotech...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release